"Stone Breaker" in Spanish — and the name is well-earned. Used for centuries in South American and Ayurvedic medicine for kidney stones and liver health, Chanca Piedra now has meaningful clinical research validating key aspects of its traditional use.
Chanca Piedra (Phyllanthus niruri) is a small tropical plant native to the Amazon rainforest, India, and other tropical regions. Its Spanish name — "chanca piedra" meaning "stone breaker" or "stone crusher" — reflects its primary traditional use: dissolving and expelling kidney stones and gallstones.
The plant has been used in Ayurvedic medicine as "bhumyamalaki" for thousands of years and in South American folk medicine for centuries. Modern phytochemical analysis has identified dozens of active compounds including phyllanthin, hypophyllanthin, quercetin, rutin, ellagic acid, and various alkaloids and lignans that collectively explain its biological activity.
Clinical research has specifically validated its use for calcium oxalate kidney stone prevention and passage — the most common type of kidney stone accounting for approximately 80% of all cases.
Chanca Piedra's phytoconstituents interfere with calcium oxalate crystal nucleation and aggregation — the process by which small crystals stick together to form larger stones. This reduces both new stone formation and growth of existing small stones.
Compounds in Chanca Piedra relax the smooth muscle of the ureter (the tube connecting kidney to bladder). This widening of the ureteral lumen facilitates easier passage of small stones and reduces the pain and spasm associated with passing a stone.
Multiple in vitro and animal studies demonstrate that Chanca Piedra compounds protect liver cells from oxidative damage and may reduce hepatic inflammation. Clinical data for liver applications is less robust than for kidney stones but supports traditional use.
A 2004 randomized controlled study by Nishiura et al. found that Chanca Piedra normalized elevated urinary calcium levels in calcium stone-forming patients versus placebo. Other research has examined reductions in additional stone-forming factors such as urinary oxalate and uric acid after supplementation.
Most relevant for: calcium oxalate stones (most common type), recurrent stone formers
Beyond prevention, Chanca Piedra helps pass existing small stones. The ureteral relaxation mechanism reduces the spasm and obstruction that makes stone passage painful and difficult. Most effective for stones under 5–6mm in diameter that can pass naturally. Not a substitute for medical treatment of large stones.
Consult a physician for any stone over 6mm or with severe pain/fever
Chanca Piedra demonstrates hepatoprotective properties in both in vitro and in vivo studies. Early research examined its use for viral hepatitis (particularly Hepatitis B), with mixed results. It has shown promise in reducing liver enzyme elevations. The antioxidant activity of its flavonoid content contributes to liver cell protection.
Note: Hepatitis B treatment requires medical supervision
Rich in quercetin, rutin, ellagic acid, and other polyphenols, Chanca Piedra exhibits significant antioxidant and free-radical scavenging activity in laboratory studies. These compounds also contribute mild anti-inflammatory effects. The clinical significance of this activity beyond kidney and liver applications is not fully established.
Antioxidant effects well-documented in vitro; clinical significance varies
Chanca Piedra works by dissolving and moving mineral deposits through the urinary tract. This process requires adequate fluid volume to carry those minerals out of the body. Without sufficient water intake, dissolved minerals can re-crystallize elsewhere.
Always take Chanca Piedra with a full glass of water and aim for at least 2–3 liters of total fluid intake per day while supplementing.
| Form | Typical Dose | Notes |
|---|---|---|
| Dried herb capsules | 500–1000mg, 3x daily | Most common form. Look for standardized extracts when possible. |
| Standardized extract | 400–800mg, 2–3x daily | More concentrated. Standardized to phyllanthin or total phenolics. |
| Tea (loose herb) | 1–2 cups daily | Traditional preparation. Bitter taste. Variable potency. |
| Liquid extract (tincture) | Per product label | Fast absorption. Convenient but alcohol-based products not for everyone. |
Divide daily dose into 2–3 servings taken throughout the day. Take with food to minimize GI upset. Drink at least one full glass of water with each dose. For kidney stone prevention, most studies used daily supplementation for 12–24 weeks.
Consult a physician for recurrent kidney stones
For general liver health support — not a substitute for medical treatment
1. Nishiura JL et al. (2004). Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol Res, 32(5), 362–366.
2. Barros ME et al. (2006). Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urol Res, 34(6), 351–357.
3. Freitas AM et al. (2002). The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int, 89(9), 829–834.
All references are peer-reviewed studies or position stands from reputable organizations.
Evidence-based supplement recommendations from a former physical store owner. No hype. No BS. Just facts.
Download Free PDF